Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

It’s estimated 5.3 million Medicare members use the 15 drugs selected today. They account for $41 billion, or 14% of part D spending, from Nov. 1, 2023, to Oct. 31, 2024. GLP-1 drug costs over ...

Wegovy (semaglutide) has a list price of $1,349.02 for a four ... Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling the cheaper, generic version of a drug ...

Consequently, people using GLP-1 medications for weight loss may litigate ... For instance, at the start of 2024, the US list prices of Ozempic (Novo Nordisk) and Mounjaro (Eli Lilly) increased ...

According to a KFF analysis, the list price for GLP-1 drugs can range between $936 and $1,349 before insurance, manufacturer coupons or rebates. As the GLP-1 patients in Al-Aly’s study were all ...

The GLP-1 drugs – I just realised I don’t actually ... put it on the medical shortage list in America. What that means, interestingly enough for very logical reasons, if you are on the list ...

The full list of key “news-flow” events in 2025 ... That asset could be one of the three GLP-1 agonist drugs Roche is guiding through clinical studies, that it acquired via is $2.7bn ...

Semaglutide was one of 15 drugs the CMS selected Friday for a second ... are also already likely to be discounted from their list prices — $998 a month for Ozempic and Rybelsus, $1,349 a month ...

Wegovy and Ozempic remain on the FDA's shortages list, despite strenuous efforts ... professionals turning to unapproved versions of GLP-1 drugs as an option for weight loss, saying: "This can ...

For its part, Hims & Hers maintains that the 'Sick of the System' ad – its first for a Super Bowl – "highlights the growing ...